EX PARTE NOVARTIS PHARMACEUTICALS CORP.

Attorney(s) appearing for the Case

Matthew H. Lembke, Kevin C. Newsom, Marc James Ayers, and Andrew L. Brasher of Bradley Arant Rose & White, LLP, Birmingham; William D. Coleman and James N. Walter, Jr., of Capell & Howard, P.C., Montgomery; and James W. Parver, Saul P. Morgenstern, Mark D. Godler, and Samuel Lonergan of Kaye Scholer, LLP, New York, New York, for petitioner Novartis Pharmaceuticals Corporation.

Thomas W. Christian, Sharon D. Stuart, and Deborah Alley Smith of Christian & Small, LLP, Birmingham; William J. Baxley, Joel E. Dillard, and Charles A. Dauphin of Baxley, Dillard, Dauphin, McKnight & Barclift, Birmingham; and D. Scott Wise and Kimberley D. Harris of Davis Polk & Wardwell, New York, New York, for petitioners AstraZeneca Pharmacuticals LP and AstraZeneca LP.

Joseph P.H. Babington and Patrick C. Finnegan of Helmsing, Leach, Herlong, Newman & Rouse, P.C., Mobile; Mark H. Lynch and Ronald G. Dove, Jr., of Covington & Burling, LLP, Washington, D.C.; Chilton D. Varner of King & Spalding, Atlanta, Georgia; and Frederick G. Herold of Dechert LLP, Mountain View, California, for petitioner SmithKline Beecham Corporation d/b/a GlaxoSmithKline.

Troy King, atty. gen.; Caine O'Rear III and Windy C. Bitzer of Hand Arendall, L.L.C., Mobile; Roger L. Bates of Hand Arendall, L.L.C., Birmingham; and Jere L. Beasley, W. Daniel Miles III, and Clinton C. Carter of Beasley, Allen, Crow, Methvin, Portis & Miles, P.C., Montgomery, for respondent State of Alabama.

Matthew C. McDonald and Kirkland E. Reid of Miller, Hamilton, Snider & Odom, L.L.C., Mobile, for amicus curiae Alabama Civil Justice Reform Committee, in support of the petitioners.

Fournier J. Gale III, Stephen C. Jackson, and Scott S. Brown of Maynard, Cooper & Gale, P.C., Birmingham, and Robin S. Conrad, National Chamber Litigation Center, of counsel, for amici curiae Business Council of Alabama and the Chamber of Commerce of the United States of America, in support of the petitioners.